A reduction-responsive self-reporting fluorescent prodrug for real-time monitoring of 5-ASA release†
Abstract
A fluorescent prodrug (NPD) was developed by conjugating 5-aminosalicylic acid with a naphthalimide fluorophore via a reduction-sensitive azo linkage. NPD exhibits quenched fluorescence but generates strong fluorescence upon reduction-triggered drug release. This system enables real-time monitoring of drug activation while maintaining therapeutic efficacy, as demonstrated by ROS-scavenging and anti-inflammatory activities.